Pinnacle Oncology Hematology

Recent papers from Pinnacle Oncology Hematology

1. Mentorship Over Infrastructure: What Drives Dermatology Residents to Pursue Pediatric Dermatology FellowshipPediatric Dermatology · 2026
2. A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM) and paricalcitol as neoadjuvant therapy in pancreatic cancerThe Oncologist · 2026
3. Abstract 3423: Integrating PDX and PDX-derived organoid platforms to enhance translational drug discovery in breast cancerCancer Research · 2026
4. A randomized phase II trial of gemcitabine, nab‐paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancerCancer · 2026
5. Anterior cruciate ligament surgeons frequently modify their approach when treating patients with knee hyperextension or ligamentous hyperlaxity: Results from an international survey of ISAKOS membersJournal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine · 2025
6. Abstract B094: Ketogenic Diet Modulates Gut Microbiome Composition and Enhances Treatment Response in Patients with Advanced Pancreatic Cancer: A Phase II StudyCancer Research · 2025
7. A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancerESMO Open · 2025
8. Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltrationMolecular Carcinogenesis · 2024
9. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorderJournal of Clinical Investigation · 2024
10. A Rare Case of Cutaneous Metastasis of Renal Cell Carcinoma to the Lateral ThighCureus · 2023
11. Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumorsInvestigational New Drugs · 2023
12. Long-term Safety of Spinal Cord Stimulation Systems in A Prospective, Global Registry of Patients With Chronic PainPain Management · 2023
13. Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ- PBMC-HPV) in HLA-A*02+ patients with HPV16+ Solid Tumors2022
14. A phase 1/2 dose escalation/expansion study of OR2805 alone or in combination in subjects with advanced solid tumors.Journal of Clinical Oncology · 2022
15. Compulsive alcohol seeking and relapse: Central role of conditioning factors associated with alleviation of withdrawal states by alcoholBritish Journal of Pharmacology · 2022
16. An International Consensus on the Design of Prospective Clinical–Translational Trials in Spatially Fractionated Radiation TherapyAdvances in Radiation Oncology · 2021
17. A small-molecule activator of the unfolded protein response eradicates human breast tumors in miceScience Translational Medicine · 2021
18. Human Papillomavirus (HPV)-Associated Squamous Cell Carcinoma In situ With Positive p16 and Ki-67 Immunohistochemical Stains in a Young Immunocompetent PatientCureus · 2020
19. BRAF -Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal CancerClinical Cancer Research · 2020
20. The gastrointestinal pathogen Campylobacter jejuni metabolizes sugars with potential help from commensal Bacteroides vulgatusCommunications Biology · 2020